Commure's partnerships enable enterprise cross-selling
Commure
These partnerships turn product development into enterprise distribution. By building with HCA, Tenet, and other large systems, Commure can test whether a tool works inside real hospital workflows, then sell the same module across a network on multi year contracts that often start around $1M and expand as more products are added. That is especially valuable in hospitals, where proving integration with Epic, Cerner, and local workflows matters as much as the AI itself.
-
The practical loop is simple. Commure launches a module like Scribe inside a large health system, learns how clinicians review notes and how data has to flow into the EHR, then uses that live proof point to shorten procurement with the next hospital customer.
-
This is different from narrower ambient AI vendors. Abridge has grown fast through deep EHR partnerships, but its main wedge is documentation. Commure uses documentation as one entry point, then cross sells revenue cycle, remote monitoring, patient engagement, and staff safety into the same enterprise account.
-
The model also explains why M&A matters so much. The Athelas merger added revenue cycle management and remote patient monitoring, and the Augmedix acquisition added documentation capacity, giving Commure more modules to bundle once a health system relationship is in place.
Going forward, the advantage will compound if Commure keeps turning pilot style partnerships into wider system rollouts. The winner in hospital AI is likely to be the company that becomes easiest to buy across multiple workflows, not the company with only the best standalone scribe.